Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Cancer Impact Fund (ICIF) is a social impact investment vehicle launched by the City Cancer Challenge Foundation (C/Can) and Social Finance to improve cancer care in low- and middle-income countries. The fund utilizes an innovative outcome-based financing model to provide upfront capital for scaling cancer diagnostic and treatment services in urban centers. By partnering with global pharmaceutical companies and local governments, ICIF aims to reduce the global equity gap in oncology and ensure sustainable access to high-quality care. The initiative focuses on measurable health improvements, such as reduced time to diagnosis and increased treatment completion rates, while attracting private capital to global health challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Cancer Impact Fund.